Huadong Medicine Co., Ltd Stock

Equities

000963

CNE0000011S1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
31.52 CNY +4.89% Intraday chart for Huadong Medicine Co., Ltd +6.96% -23.97%
Sales 2024 * 45.21B 6.24B Sales 2025 * 50.02B 6.91B Capitalization 55.16B 7.62B
Net income 2024 * 3.43B 473M Net income 2025 * 4.24B 585M EV / Sales 2024 * 1.12 x
Net cash position 2024 * 4.46B 615M Net cash position 2025 * 6.35B 877M EV / Sales 2025 * 0.98 x
P/E ratio 2024 *
16.1 x
P/E ratio 2025 *
13 x
Employees 14,061
Yield 2024 *
1.48%
Yield 2025 *
1.79%
Free-Float 41.75%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.89%
1 week+6.96%
Current month+1.68%
1 month-6.66%
3 months-9.56%
6 months-23.86%
Current year-23.97%
More quotes
1 week
29.05
Extreme 29.05
31.97
1 month
28.90
Extreme 28.9
33.64
Current year
27.60
Extreme 27.6
41.45
1 year
27.60
Extreme 27.6
46.43
3 years
27.60
Extreme 27.6
53.94
5 years
16.02
Extreme 16.02
53.94
10 years
11.67
Extreme 11.6722
53.94
More quotes
Managers TitleAgeSince
Director of Finance/CFO 53 -
Chairman 78 71-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 50 02-12-31
Chairman 78 71-12-31
Director/Board Member 56 -
More insiders
Date Price Change Volume
24-04-18 31.52 +4.89% 27,738,660
24-04-17 30.05 +1.90% 12,517,050
24-04-16 29.49 -0.03% 11,278,550
24-04-15 29.5 +1.72% 10,756,690
24-04-12 29 -1.59% 9,809,632

End-of-day quote Shenzhen S.E., April 17, 2024

More quotes
Huadong Medicine Co., Ltd. specializes in the development, manufacture and marketing of medical products and vaccines. The products are intended primarily for the treatment of tumors, immune disorders, endocrine disorders, orthopedic and traumatological disorders, digestive system diseases and viral diseases.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
31.52 CNY
Average target price
50.51 CNY
Spread / Average Target
+60.25%
Consensus
  1. Stock Market
  2. Equities
  3. 000963 Stock